•  
  •  
 

Abstract

A case-control study at AL-Sadar Teaching Hospital/Al-Najaf Center found a negative correlation between serum omentin-1 levels and diabetic nephropathy, suggesting early detection of microvascular complications. Long-term diabetes increases the risk of complications, including nephropathy, which worsens over time. High blood pressure is a common comorbidity among diabetics, and careful glycemic control is necessary in advanced stages. Omentin-1 plays a role in enhancing insulin sensitivity and glucose metabolism, but further investigation is needed to determine diabetic nephropathy severity in T2DM patients.

References

1] John JE, John NA. Imminent risk of covid-19 in diabetes mellitus and undiagnosed diabetes mellitus patients. Pan African Medical Journal 2020 May 1;36:1e5. https://doi.org/ 10.11604/pamj.2020.36.1.22389.

[2] Thipsawat S. Early detection of diabetic nephropathy in a patient with type 2 diabetes mellitus: a review of the literature. Diabetes Vasc Dis Res 2021;18. https://doi.org/10.1177/ 14791641211010295.

[3] Lempi€ainen P, Mykkanen L, Py € or€ al € €a K, Laakso M, Kuusisto J. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 1999;100(2): 123e8. https://doi.org/10.1161/01.cir.100.2.123.

[4] Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006; 119(10):812e9. https://doi.org/10.1016/j.amjmed.2006.02. 031.

[5] Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middleaged men. JAMA 2002;288(21):2709e16. https://doi.org/ 10.1001/jama.288.21.2709.

[6] Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buleon M, et al. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metabol 2008;8(5):437e45. https://doi.org/10.1016/j.cmet.2008.10.003.

[7] Gamble J, Lopaschuk GD. Insulin inhibition of 50 adenosine monophosphatedactivated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation. Metabolism 1997;46(11): 1270e4. https://doi.org/10.1016/S0026-0495(97)90218-1.

[8] Glassford AJ, Yue P, Sheikh AY, Chun HJ, Zarafshar S, Chan DA, et al. HIF-1 regulates hypoxia-and insulininduced expression of apelin in adipocytes. Am J Physiol Endocrinol Metabol 2007;293(6):E1590e6. https://doi.org/ 10.1152/ajpendo.00343.2007.

[9] Habata Y, Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Hinuma S, et al. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta Mol Cell Res 1999;1452(1):25e35. https:// doi.org/10.1016/S0167-4889(99)00114-7.

[10] Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ. Evidence for 50 AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998;47(8):1369e73. https://doi.org/ 10.2337/diabetes.47.8.1369.

[11] Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. American J Phys-Endocrin Metabol 2006;290(6): E1253e61. https://doi.org/10.1152/ajpendo.00572.2005.

[12] Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol 2017;12(12):2032e45. https://doi.org/10.2215/CJN. 11491116.

[13] Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 32(1):193e203. https://doi.org/10.2337/dc08-9025.

[14] Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner R. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma MA'AEN JOURNAL FOR MEDICAL SCIENCES 2025;4:17e22 21 glucose and insulin concentrations in man. Diabetologia 1985;28:412e9. https://doi.org/10.1007/BF00280883.

[15] Tan BK, Adya R, Farhatullah S, Lewandowski KC, O'Hare P, Lehnert H, et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 2008;57(4):801e8. https:// doi.org/10.2337/07-0990.

[16] de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007;56(6):1655e61. https:// doi.org/10.2337/06-1506.

[17] Cheung A, Chang T, Cushman W, Furth S, Hou F, Ix J, et al. KDIGO 2021 Clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Intern 2021;99(3):S1e87. https://doi.org/10.1016/j.kint.2020.10.020.

[18] Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variation with increase levels of HbA1c. Diabetes Care 2003;26(3): 881e5. https://doi.org/10.2337/diacare.26.3.881.

[19] Shibata R, Ouchi N, Ohashi K. Omentin as a novel biomarker of metabolic risk factors. Diabetic Res Clinic Prac 2012. https://doi.org/10.1016/j.diabres.2011.12.0022.

[20] Xiong Y, Zhou J, Zhang L, Tan B, Yu J, Wang Y. Omentin-1 protects pancreatic b-cells from dysfunction and apoptosis in a diabeticmousemodel. Diabetes,Metab Syndrome Obes Targets Ther 2020;13:1077e86. https://doi.org/10.2147/DMSO.S241432.

[21] Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, et al. Circulating omentin-1 levels in relation to insulin sensitivity and glycemic control in type 2 diabetes. J Clin Endocrinol Metabol 2014;99(2):E505e10. https://doi.org/10.1210/jc.2013-2767.

[22] Yan P. Circulating omentin-1 levels are associated with insulin sensitivity, glycemic control, and inflammation in type 2 diabetes. J Diabetes Complicat 2019;33(7):485e9.

[23] Askin L. Low omentin-1 levels in gestational diabetes mellitus: a predictor of poor g

Download

Share

COinS